restrict
cellular
infect
multipl
import
viral
pathogen
particularli
critic
innat
immun
respons
influenza
viru
express
expand
acid
endolysosom
compart
prevent
fusion
endocytos
virus
lead
degrad
small
amino
acid
antivir
protein
control
least
four
distinct
posttransl
modif
posit
regul
antivir
activ
provid
spalmitoyl
neg
regulatori
mechan
includ
lysin
ubiquitin
lysin
methyl
tyrosin
phosphoryl
herein
describ
specif
insight
traffick
activ
provid
studi
posttransl
modif
discuss
evid
suggest
adopt
multipl
membran
topolog
involv
least
one
intramembran
domain
antivir
activ
conform
three
palmitoyl
cystein
one
methyl
four
ubiquitin
lysin
phosphoryl
tyrosin
gene
duplic
human
result
presenc
ifitm
mice
encod
least
seven
homolog
ifitm
gene
ifitm
gene
present
mice
lost
abil
produc
protein
product
consid
pseudogen
mous
human
ifitm
show
mostli
overlap
abil
inhibit
differ
virus
overexpress
assay
vitro
though
ifn
induc
differ
antivir
function
observ
recent
review
uniqu
role
specif
ifitm
also
emerg
genet
studi
vivo
experiment
exampl
express
specif
bone
evolv
perform
critic
role
osteoblast
function
bone
miner
hand
essenti
restrict
influenza
viru
infect
mice
human
knockout
mice
develop
sever
influenza
viru
infect
succumb
dose
viru
subleth
wildtyp
mice
interestingli
viral
infect
exacerb
compar
knockout
mice
mice
defici
ifitm
importantli
genet
polymorph
splice
site
human
gene
thought
result
truncat
less
activ
protein
associ
sever
case
influenza
viru
infect
taken
togeth
data
suggest
ifitm
abl
compens
loss
restrict
influenza
viru
infect
vivo
thu
much
recent
work
focus
understand
molecular
mechan
control
viru
restrict
herein
provid
model
activ
incorpor
current
knowledg
posttransl
regul
palmitoyl
ubiquitin
methyl
phosphoryl
studi
ptm
provid
insight
traffick
membran
topolog
activ
may
ultim
provid
entri
point
manipul
therapeut
purpos
shown
inhibit
viral
infect
prevent
viru
fusion
endolysosom
membran
accord
earli
studi
use
retrovirus
pseudotyp
distinct
viral
surfac
protein
show
inhibit
infect
depend
upon
viral
glycoprotein
use
entri
fusion
comprehens
list
virus
shown
inhibit
ifitm
recent
compil
confirm
major
virus
inhibit
includ
influenza
viru
sar
coronaviru
dengu
viru
west
nile
viru
among
mani
other
share
common
abil
enter
cell
via
endocytosi
util
phdepend
fusion
mechan
convers
sendai
viru
moloney
leukemia
viru
fuse
cell
surfac
modestli
affect
addit
treatment
sar
conronaviru
trypsin
allow
viru
fuse
cell
surfac
elimin
need
proteolyt
activ
cathepsin
l
lysosom
result
viru
evas
restrict
dimer
local
marker
endosom
lysosom
compart
character
increas
size
decreas
ph
cell
express
work
hyperact
mutant
lack
ubiquitin
site
suggest
endosom
acid
lysosom
aberrantli
merg
upon
express
provid
compart
viral
degrad
explain
refer
compart
endolysosom
compart
also
stain
posit
autophagosom
marker
characterist
multivesicular
bodi
visual
electron
microscopi
indic
effect
endocyt
pathway
multifacet
inde
influenza
viru
particl
visual
enter
cell
express
elimin
degrad
prior
fusionescap
endolysosom
expans
alter
endolysosom
compart
cell
inhibit
influenza
viru
found
independ
canon
autophagi
protein
autophagi
induct
pathway
may
involv
interact
vacuolar
atpas
confluenc
data
discuss
support
model
wherebi
virus
degrad
acid
endolysosom
cell
figur
howev
model
contain
paradox
influenza
viru
fusion
normal
trigger
lower
ph
late
endosom
yet
fusion
appar
prevent
lowph
endolysosom
present
figur
two
primari
theori
emerg
explain
inhibit
viral
fusion
theori
stem
observ
increas
cholesterol
level
present
within
endolysosom
cell
express
compar
control
cell
chang
cholesterol
shown
depend
upon
interact
vapa
interrupt
homeostat
partnership
vapa
cholesterol
traffick
protein
propon
theori
posit
dysregul
cholesterol
homeostasi
respons
viru
inhibit
howev
recent
public
challeng
notion
show
minim
effect
either
cholesterol
deplet
modul
vapa
level
activ
likewis
niemannpick
type
fibroblast
contain
high
level
cholesterol
late
endosom
compart
show
littl
chang
influenza
viru
infect
compar
control
cell
thu
though
potenti
complementari
antivir
function
remain
unclear
whether
cholesterol
dysregul
essenti
primari
mechan
action
theori
arisen
two
independ
studi
demonstr
decreas
membran
fluiditi
cell
express
ifitm
necess
membran
fluiditi
effici
fusion
multitud
virus
appreci
decad
though
ifninduc
enzym
influenc
membran
lipid
composit
would
first
cellular
antivir
effector
limit
infect
directli
alter
rigid
cell
membran
discov
molecular
detail
alter
structur
featur
endolysosom
membran
inhibit
viru
fusion
deciph
potenti
role
cholesterol
dysregul
may
play
process
excit
area
futur
research
palmitoyl
enzymat
addit
fatti
acid
protein
often
occur
cystein
residu
known
spalmitoyl
refer
thioester
linkag
fatti
acid
sulfurbear
side
chain
hydrophob
modif
result
membran
attach
otherwis
cytoplasm
protein
palmitoyl
also
varieti
effect
protein
alreadi
membraneassoci
includ
target
specif
cellular
compart
modul
protein
interact
stabil
modul
protein
structur
posit
membran
identifi
chemic
proteom
screen
design
detect
immunityrel
protein
posttransl
palmitoyl
time
report
antivir
activ
yet
wellestablish
induct
type
ifn
prompt
us
investig
ptm
potenti
antivir
function
abl
confirm
spalmitoyl
occur
three
cystein
within
adjac
two
hydrophob
domain
posit
palmitoylationdefici
tripl
cysteinetoalanin
mutant
show
diffus
pattern
local
wildtyp
indic
spalmitoyl
promot
cluster
also
suggest
despit
two
hydrophob
stretch
predict
transmembran
domain
fraction
may
associ
membran
inde
cellular
fraction
experi
indic
signific
amount
endogen
strongli
membranebound
membran
associ
increas
spalmitoyl
importantli
also
found
overexpress
abl
inhibit
influenza
viru
infect
varieti
cell
type
effect
larg
lost
upon
mutat
spalmitoyl
cystein
concurr
least
three
addit
group
also
identifi
antivir
effector
protein
activ
multipl
virus
largescal
screen
studi
provid
valid
antivir
effect
observ
suggest
palmitoyl
like
import
innat
immun
varieti
infect
altern
lipid
modif
site
ad
nand
ctermini
myristoyl
prenyl
respect
abl
rescu
membran
affin
antivir
activ
palmitoylationdefici
mutant
suggest
spalmitoyl
act
induc
structur
chang
hydrophob
region
rather
act
increas
membran
affin
thu
studi
spalmitoyl
would
indic
proper
membran
anchor
potenti
also
cluster
featur
mediat
spalmitoyl
essenti
antivir
function
spalmitoyl
conserv
ifitm
test
date
human
ifitm
mous
ifitm
inde
palmitoyl
cystein
among
conserv
ifitm
residu
present
throughout
evolut
interestingli
palmitoyl
murin
essenti
prevent
proteasom
degrad
palmitoyl
human
necessari
interact
factor
regul
abil
promot
bone
format
suggest
though
spalmitoyl
conserv
modif
may
distinct
effect
differ
ifitm
palmitoyltransferas
respons
modifi
ifitm
yet
identifi
enzym
may
repres
novel
viru
suscept
factor
polymorph
human
popul
exist
render
unabl
modifi
thu
warrant
identif
studi
ubiquitin
addit
kda
ubiquitin
polypeptid
protein
usual
lysin
upon
overexposur
western
blot
specif
band
kda
expect
molecular
weight
observ
approxim
kda
correspond
shift
would
predict
monoand
diubiquitin
respect
immuneprecipit
examin
upper
band
msm
ubiquitin
peptid
lysinecontain
peptid
coval
modifi
diglycin
motif
characterist
signatur
ubiquitin
remain
follow
trypsin
digest
identifi
sever
largescal
ms
studi
aim
identifi
ubiquitin
protein
also
identifi
variou
ifitm
substrat
ubiquitin
ms
result
confirm
antiubiquitin
blot
immunoprecipit
reveal
also
polyubiquitin
linkag
polyubiquitin
linkag
often
control
protein
turnov
traffick
respect
suggest
ubiquitin
multipl
effect
contain
four
conserv
lysin
construct
three
four
lysin
mutat
alanin
allow
demonstr
ubiquitin
occur
four
posit
though
appear
strongli
modifi
residu
particularli
polyubiquitin
chain
howev
mutagenesi
result
overt
chang
antivir
activ
local
abund
indic
lysin
may
function
compens
role
ubiquitin
residu
fact
novel
phenotyp
observ
four
lysin
mutat
alanin
lysineless
show
increas
stabil
pulsechas
experi
local
entir
endolysosom
lose
overlap
endoplasm
reticulum
er
marker
observ
portion
wildtyp
may
suggest
ubiquitin
recruit
erproxim
site
degrad
hyperact
also
observ
ubiquitinationdefici
lysineless
mutant
inhibit
influenza
viru
correl
complet
local
endolysosom
therebi
support
model
antivir
activ
endolysosom
local
essenti
specif
role
differ
linkag
polyubiquitin
chain
remain
decrypt
likewis
ubiquitin
ligas
respons
modifi
yet
identifi
avail
data
suggest
ubiquitin
neg
regul
stabil
activ
enzym
identifi
may
repres
possibl
therapeut
target
improv
antivir
immun
respons
addit
ubiquitin
also
monomethyl
lysin
methyltransferas
initi
report
methyl
histon
asid
predomin
methyl
chromatin
primari
local
nucleu
also
methyl
sever
cellular
nonhiston
protein
hiv
protein
tat
thu
one
grow
list
protein
reportedli
regul
monomethyl
discov
use
ms
confirm
upon
develop
monoclon
antibodi
studi
methyl
increas
overexpress
correl
loss
antivir
activ
convers
knockdown
decreas
methyl
result
enhanc
restrict
influenza
viru
vesicular
stomat
viru
interestingli
infect
either
virus
increas
methyl
measur
earli
h
post
infect
treatment
decreas
methyl
sinc
net
result
viru
infect
increas
methyl
despit
presum
induct
type
ifn
may
suggest
virus
activ
promot
methyl
immun
evas
strategi
clear
import
methyl
establish
experi
modul
level
make
surpris
mutat
result
major
chang
activ
influenza
viru
dengu
viru
vesicular
stomat
viru
also
ubiquitin
prevent
two
neg
regulatori
modif
mutat
might
expect
increas
antivir
activ
howev
analog
abil
multipl
lysin
ubiquitin
compensatori
methyl
may
occur
anoth
lysin
absenc
requir
investig
continu
studi
determin
effect
methyl
proteinprotein
interact
stabil
modif
ptm
aid
mechanist
character
effect
modif
despit
withstand
question
capabl
affect
antivir
activ
knowledg
broaden
repertoir
enzym
repres
potenti
target
antivir
therapi
phosphoryl
identifi
mous
human
mediat
srcfamili
proteintyrosin
kinas
fyn
larg
conserv
throughout
evolut
recent
work
identifi
involv
sort
motif
denot
tyrosin
x
amino
acid
denot
valin
leucin
isoleucin
critic
endocytosi
disrupt
motif
mutagenesi
led
accumul
plasma
membran
loss
antivir
activ
increas
phosphoryl
motif
fyn
overexpress
led
similar
accumul
plasma
membran
suggest
phosphoryl
act
neg
regul
activ
block
motif
interact
endocyt
adaptor
complex
fact
work
jia
et
al
identifi
complex
essenti
traffick
endolysosom
recognit
tetrapeptid
note
ifitm
lack
motif
human
show
increas
local
plasma
membran
may
partial
explain
differ
activ
observ
compar
overexpress
assay
perhap
inabl
compens
endogen
level
similarli
human
gene
polymorph
associ
increas
sever
influenza
viru
infect
predict
result
truncat
first
amino
acid
nterminu
thu
protein
defect
antivir
activ
may
explain
least
part
loss
motif
thu
proper
traffick
endolysosom
initi
predict
phosphoryl
retent
plasma
membran
might
also
allow
recruit
ubiquitin
ligas
mark
degrad
sinc
phosphoryl
often
serv
cue
process
contrari
found
increas
phosphoryl
overexpress
fyn
mutat
significantli
decreas
ubiquitin
suggest
unmodifi
might
also
critic
compon
ubiquitin
ligas
recognit
motif
inde
motif
note
conform
ppxi
pattern
recogn
hect
domaincontain
ubiquitin
ligas
though
date
function
ascrib
sequenc
studi
phosphoryl
reveal
import
detail
regard
local
traffick
provid
evid
local
plasma
membran
prior
traffick
endolysosom
fyn
cotransl
myristoyl
postransl
palmitoyl
rapidli
target
anchor
cytoplasm
leaflet
plasma
membran
direct
interact
support
notion
natur
traffic
plasma
membran
fyn
play
critic
role
sever
biolog
process
includ
tcell
signal
cell
surviv
cell
adhesionmedi
signal
kept
inact
state
phosphoryl
ctermin
tyrosin
csrc
kinas
activ
dephosphoryl
protein
tyrosin
phosphatas
interestingli
tyrosin
phosphoryl
difficult
detect
without
pretreat
cell
protein
tyrosin
phosphatas
inhibitor
suggest
phosphoryl
also
revers
dynam
process
precis
natur
phosphatas
involv
regul
fyn
remain
identifi
knowledg
may
aid
understand
sequenc
event
involv
phosphoryl
dephosphoryl
well
physiolog
trigger
addit
remov
ptm
membran
topolog
subject
controversi
evid
suggest
adopt
multipl
conform
antivir
activ
topolog
topic
debat
understand
characterist
activ
essenti
understand
biophys
interact
cellular
membran
interact
cellular
protein
ultim
mechan
antivir
action
howev
presenc
multipl
cellular
compart
includ
plasma
membran
er
autophagosom
multivesicular
endolysosom
along
potenti
multipl
topolog
discuss
made
tradit
topolog
map
proteas
digest
protect
assay
difficult
interpret
unpublish
data
thu
method
includ
map
ptm
use
infer
membran
topolog
predict
dualpass
transmembran
protein
nand
ctermini
face
lumen
cellular
organel
er
endolysosom
extracellular
space
figur
inde
epitop
tag
termini
detect
extracellularli
antibodi
stain
nonpermeabil
cell
addit
antibodi
bind
region
link
two
hydrophob
domain
requir
deterg
permeabil
stain
cell
indic
region
entir
intracellular
likewis
posit
three
conserv
spalmitoyl
cystein
consist
dual
transmembran
topolog
overal
data
would
suggest
portion
inde
exist
dualpass
transmembran
protein
figur
howev
fraction
cellular
cytoplasm
membran
compart
indic
signific
portion
present
cytoplasm
word
strongli
membraneassoci
lack
er
signal
sequenc
nterminu
also
make
unclear
precis
effici
membran
insert
might
occur
fraction
result
reminisc
obtain
palmitoyl
protein
hydrophob
segment
fulli
travers
membran
rather
form
propos
hairpinlik
structur
within
membran
known
intramembran
domain
evolutionari
studi
ifitm
identifi
ten
addit
human
gene
like
relat
ifitm
examin
whether
topolog
map
protein
product
gene
previous
perform
membran
topolog
data
one
ifitm
rel
known
indic
second
hydrophob
stretch
protein
intramembran
domain
figur
topolog
map
addit
nine
rel
ifitm
remain
perform
nonetheless
work
provid
preced
presenc
intramembran
domain
within
famili
protein
also
accord
previou
predict
second
hydrophob
domain
ifitm
may
true
transmembran
domain
due
lack
suffici
anchor
residu
ctermini
ifitm
speci
truncat
region
could
activ
possess
intramembran
domain
rather
transmembran
domain
discuss
propos
possibl
base
first
observ
portion
strongli
membraneassoci
palmitoyl
increas
membran
affin
addit
analysi
ptm
support
notion
nterminu
activ
orient
toward
cytoplasm
rather
extracellularli
predict
first
ubiquitin
like
occur
cytoplasm
sinc
dogmat
locat
ubiquitin
ligas
second
conserv
residu
phosphoryl
cytoplasm
kinas
fyn
importantli
part
motif
interact
cytoplasm
complex
essenti
endocytosi
local
endolysosom
thu
cytoplasm
orient
nterminu
essenti
proper
local
activ
might
also
conclud
data
stain
nterminusdirect
antibodi
cell
surfac
nonpermeabil
cell
repres
antivir
activ
also
demonstr
nterminu
construct
append
myristoyl
motif
modifi
cytoplasm
myristoyl
machineri
modif
support
membran
associ
antivir
activ
vein
natur
occur
nlink
glycosyl
consensu
sequenc
nterminu
minim
modifi
erlumen
glycosyl
machineri
likewis
addit
glycosyl
site
engin
within
nand
ctermin
region
mostli
unmodifi
agre
cytoplasmfac
orient
domain
major
protein
thu
overwhelm
data
support
activ
cytoplasm
orient
nterminu
result
gener
consensu
first
hydrophob
stretch
within
activ
like
act
intramembran
domain
figur
conflict
evid
exist
concern
whether
second
hydrophob
stretch
within
activ
fulli
travers
membran
bilay
stain
cell
surfac
stronger
stain
ctermin
epitop
tag
compar
ntermin
tag
suggest
signific
fraction
second
hydrophob
domain
fulli
span
plasma
membran
also
report
extens
cterminu
partial
cleav
lysosom
work
suggest
signific
fraction
cellular
exist
type
ii
transmembran
protein
figur
support
topolog
model
untag
human
recent
demonstr
adopt
type
ii
transmembran
topolog
significantli
extend
ctermin
domain
compar
local
primarili
cell
surfac
relev
topolog
determin
relat
clear
likewis
import
type
ii
transmembran
conform
antivir
activ
remain
demonstr
particularli
sinc
percentag
cellular
adopt
topolog
determin
model
develop
use
construct
ctermin
epitop
tag
doubl
length
ctermin
domain
potenti
alter
abil
anchor
transmembran
region
convers
append
ctermin
caax
box
prenyl
cytoplasm
enzym
activ
influenza
viru
likewis
murin
protein
nonconserv
cystein
present
within
cterminu
cytoplasm
spalmitoyl
contribut
antivir
activ
overal
addit
experi
involv
endogen
creativ
engin
construct
report
topolog
activ
requir
conclus
determin
antivir
activ
membran
topolog
ptm
analysi
reveal
dynam
traffick
sever
compart
within
cell
identif
phosphoryl
site
led
discoveri
residu
part
endocyt
motif
also
play
role
control
ubiquitin
work
suggest
default
traffic
plasma
membran
sort
least
three
distinct
way
figur
phosphoryl
fyn
therebi
block
endocyt
motif
caus
retent
plasma
membran
ubiquitin
traffick
away
plasma
membran
endolysosom
erproxim
site
degrad
traffic
via
complex
endolysosom
exert
antivir
function
alter
organel
membran
properti
endosom
lysosom
aberrantli
merg
virus
unabl
fuse
intramembran
domain
though
rare
found
protein
inf
luenc
membran
fluiditi
curvatur
known
bilay
coupl
effect
word
lipid
two
membran
leaflet
stay
coupl
one
anoth
even
intramembran
domain
wedg
one
side
lipid
bilay
consist
role
specif
perturb
outer
leaflet
endolysosom
membran
recent
studi
found
hemifus
indic
mix
viral
lipid
inner
leaflet
endolysosom
occur
fusion
pore
leaflet
endolysosom
bilay
achiev
thu
excit
specul
intramembran
domain
necessari
compon
perturb
endolysosom
membran
futur
experi
interrog
role
intramembran
domain
antivir
activ
determin
precis
effect
membran
properti
cellular
compart
facilit
palmitoyl
whether
associ
disassoci
membran
equilibrium
absenc
palmitoyl
remain
determin
figur
likewis
remain
fulli
determin
methyl
occur
ultim
effect
cours
infect
vivo
figur
similarli
crosstalk
exist
modif
yet
fulli
examin
like
shed
light
traffick
antivir
activ
also
like
addit
yet
discov
mode
posttransl
regul
occur
serin
threonin
phosphoryl
variou
form
oxid
continu
inform
understand
stabil
traffick
differ
ifitm
isoform
intrigu
find
also
requir
investig
ifitm
capabl
inhibit
hiv
replic
mechan
distinct
inhibit
virus
final
despit
effect
endolysosom
compart
often
coopt
intracellular
bacteria
role
inhibit
bacteria
observ
upon
examin
multipl
bacteri
pathogen
interest
determin
whether
bacteria
activ
evad
endolysosom
compart
perhap
alter
ptm
benefit
whether
affect
concurr
viral
infect
given
broadrang
import
innat
respons
endocyt
virus
answer
open
question
bring
us
closer
control
util
prevent
therapeut
antivir
strategi
background
inhibit
cellular
infect
influenza
viru
mani
endocyt
virus
knockout
mice
suscept
wildtyp
mice
lowdos
infect
influenza
viru
polymorph
human
gene
associ
increas
risk
sever
versu
mild
influenza
viru
infect
express
induc
enlarg
acid
endolysosom
compart
endocytos
virus
local
degrad
prevent
fusion
pore
format
viru
endolysosom
affect
cholesterol
homeostasi
decreas
membran
fluiditi
potenti
explain
abil
inhibit
viru
fusion
spalmitoyl
occur
three
membraneproxim
cystein
spalmitoyl
promot
cluster
membran
requir
full
antivir
activ
make
modif
posit
regul
antivir
activ
monoand
polyubiquitin
occur
four
lysin
ubiquitin
linkag
observ
ubiquitin
result
local
endoplasm
reticulumproxim
compart
degrad
lysineless
mutant
possess
enhanc
antivir
activ
suggest
ubiquitin
neg
regul
activ
methyl
overexpress
decreas
antivir
activ
knockdown
increas
activ
indic
methyl
play
neg
regulatori
role
phosphoryl
kinas
fyn
tyrosin
phosphoryl
block
motif
necessari
interact
complex
endocytosi
thu
local
endolysosom
antivir
activ
therefor
phosphoryl
neg
regul
activ
predict
dualpass
transmembran
protein
termini
face
extracellularli
nterminu
must
cytoplasm
locat
order
proper
local
activ
along
presenc
ptm
instal
cytoplasm
enzym
nterminu
suggest
first
hydrophob
region
act
intramembran
domain
fulli
span
lipid
bilay
whether
second
hydrophob
domain
within
antivir
activ
act
transmembran
intramembran
domain
fulli
elucid
data
describ
support
shown
topolog
model
hydrophob
segment
shown
red
dual
transmembran
topolog
predict
base
hydropathi
plot
howev
first
hydrophob
segment
adopt
intramembran
conform
requir
ntermin
access
cytoplasm
compon
necessari
proper
local
activ
whether
second
hydrophob
segment
activ
travers
membran
leaflet
remain
unclear
yellow
circl
repres
conserv
cystein
known
palmitoyl
note
cystein
first
hydrophob
segment
appear
earlier
within
segment
cystein
make
deepli
embed
membran
less
like
palmitoyl
third
cystein
absent
agre
experiment
determin
topolog
potenti
chang
membran
properti
induc
intramembran
domain
graphic
depict
alter
membran
curvatur
depict
dimer
initi
local
plasma
membran
tyrosin
p
yellow
star
fyn
retain
plasma
membran
prevent
interact
endocyt
adaptor
complex
unknown
ptase
dynam
remov
phosphoryl
allow
endocytosi
target
endolysosom
viru
degrad
altern
unphosphoryl
target
ubiquitin
u
orang
circl
yet
unidentifi
ubiquitin
ligas
result
misloc
degrad
palmitoyl
small
green
box
current
unidentifi
dhhcanchor
membran
promot
cluster
necessari
antivir
activ
locat
palmitoyltransferas
activ
current
unknown
depict
endolysosom
portion
nonpalmitoyl
cytoplasm
may
fraction
encount
cytoplasm
methyl
pink
polygon
decreas
antivir
activ
unknown
mechan
el
endolysosom
p
phosphoryl
ptase
phosphatas
